Personalised mRNA cancer vaccines are still in development. They are designed to teach and activate the body’s immune system to recognise, hunt down and attack cancer cells. 

Cancer vaccines are a class of immunotherapy that is still in development. No cancer vaccines are currently licenced for use in standard cancer care – patients can only access them through clinical trials. 

Unlike traditional vaccines (such as for flu or COVID-19), cancer vaccines are not designed to prevent the disease. They are being designed and tested as a potential new way to treat cancer.